| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744469 | 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate | 0.0171490505199911 | 0.15629953 |
| NSC 90810 | Null | 0.0171490505199911 | 0.018107302 |
| NSC 691250 | Null | 0.0178844438004194 | 0.067388691 |
| NSC 707484 | Null | 0.0178844438004194 | -0.056799983 |
| NSC 714408 | Null | 0.0178844438004194 | 0.16013876 |
| NSC 735186 | 4'-(1H-benzimidazol-2-yl)1,1biphenyl-4-amine | 0.0178844438004195 | 0.13974545 |
| NSC 132230 | Null | 0.0186186224062459 | 0.090056059 |
| NSC 315626 | Butyric acid, rhodium salt (4:2) | 0.0186186224062459 | 0.20963607 |
| NSC 638287 | Null | 0.0186186224062459 | 0.11709091 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0220039422291536 | -0.14584069 |